Trial Profile
A Randomized, Double-blind, Placebo-controlled Study of Megestrol Acetate Concentrated Suspension for the Treatment of Cancer-associated Anorexia in Subjects With Cancer of Multiple Types
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Megestrol (Primary)
- Indications Anorexia; Cachexia
- Focus Therapeutic Use
- Sponsors Par Pharmaceutical Inc
- 31 Mar 2016 Time frame for primary endpoints changed from 'daily intake' to '8 weeks'.
- 22 Oct 2014 New trial record